Jagadeswara Rao Earla

8PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersSocial epidemiologyEpidemiological modellingPharmacogenomicsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 04, 2025
Factors influencing Patient Preferences for BRCA Testing and Adjuvant Therapy in HER2-Negative Early Breast Cancer in the United States: Best-Worst Scaling and Discrete Choice Experiment.

Kathryn Mishkin, Qixin Li, Jagadeswara Rao Earla

|Aug 22, 2025
Patient characteristics, treatment patterns, and clinical outcomes in HER2-negative early breast cancer by germline BRCA status.

Jay A Andersen, Jagadeswara Rao Earla, Nicole Fulcher

|Dec 16, 2024
Correlation Between Disease-Free Survival Endpoints and Overall Survival in Elderly Patients with Early-Stage HER2-Negative Breast Cancer: A SEER-Medicare Analysis.

Jagadeswara R Earla, Allison W Kurian, Kalé Kponee-Shovein

|Dec 09, 2024
Real-world perioperative treatment patterns and economic burden of recurrence in early-stage HER2-negative breast cancer: a SEER-Medicare study.

Jagadeswara Rao Earla, Kalé Kponee-Shovein, Allison W Kurian

|May 09, 2023
Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis.

Jagadeswara Rao Earla, Jieni Li, George J Hutton

|Feb 28, 2021
Comparative treatment effectiveness of oral fingolimod and conventional injectable disease-modifying agents in multiple sclerosis.

Jagadeswara R Earla, George J Hutton, Douglas J Thornton

Pageof 2

Frequent Collaborators

3 joint publications

Rajender R Aparasu

2 joint publications

J Douglas Thornton

2 joint publications

Hua Chen

2 joint publications

Kim M Hirshfield